(Updated - April 21, 2022 6:14 AM EDT)

Citi analyst Yigal Nochomovitz downgraded Arcturus Therapeutics (NASDAQ: ARCT) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE